HSKA — Heska Income Statement
0.000.00%
HealthcareAdventurousMid Cap
- $1.31bn
- $1.28bn
- $257.31m
Annual income statement for Heska, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 127 | 123 | 197 | 254 | 257 |
Cost of Revenue | |||||
Gross Profit | 56.6 | 54.4 | 81.3 | 106 | 111 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 124 | 122 | 206 | 255 | 278 |
Operating Profit | 3.79 | 0.327 | -8.19 | -0.993 | -20.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3.81 | -2.58 | -13.8 | -3.44 | -21.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.92 | -1.14 | -14 | 0.132 | -18.4 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5.85 | -1.47 | -14.4 | -1.15 | -19.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.85 | -1.47 | -14.4 | -1.15 | -19.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.36 | -0.111 | -0.452 | -0.099 | -0.671 |